Prosecution Insights
Last updated: April 19, 2026

BIVICTRIX LIMITED

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18215953 ANTI-CD33 AND ANTI-CD7 COMBINATION TREATMENT SANG, HONG 1646 Non-Final OA Jun 29, 2023
18265781 BISPECIFIC ANTIBODIES BINDING TO CD7 AND CD33 MERTZ, PREMA MARIA 1674 Non-Final OA Jun 07, 2023

Managing BIVICTRIX LIMITED's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month